{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:56:54Z","timestamp":1760648214208,"version":"build-2065373602"},"reference-count":16,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>We report a rare case of pulmonary tumor thrombotic microangiopathy (PTTM) in a patient with metastatic neurotrophic tropomyosin receptor kinase (NTRK) fusion-positive transverse colon cancer who exhibited a marked radiologic and biochemical response to entrectinib. Despite significant tumor shrinkage, progressive dyspnea and hypoxemia developed approximately four weeks after therapy initiation. Chest CT revealed diffuse interstitial infiltrates, initially interpreted as drug-induced pneumonitis or infection. Entrectinib was discontinued, but respiratory failure progressed, and the patient died shortly thereafter. Autopsy revealed widespread pulmonary microangiopathy with fibrocellular intimal proliferation and tumor emboli in small pulmonary arteries, consistent with PTTM. Notably, no hematogenous metastases were identified; instead, tumor spread appeared to occur via an atypical lymphatic route through the thoracic duct. The tumor exhibited microsatellite stability and a modest mutation burden, suggesting that lymphatic dissemination and microvascular pathology may progress independently of these genomic features. This case underscores a critical dissociation between oncologic response and vascular complications, indicating that tropomyosin receptor kinase (TRK) inhibitor monotherapy may be insufficient to prevent PTTM. Comprehensive management may require concurrent strategies targeting the pulmonary microvasculature, including antiangiogenic therapy and modulation of cytokine and growth factor signaling.<\/jats:p>","DOI":"10.3390\/curroncol32090506","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:23:50Z","timestamp":1757600630000},"page":"506","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dissociation Between Tumor Response and PTTM Progression During Entrectinib Therapy in NTRK Fusion-Positive Colon Cancer"],"prefix":"10.3390","volume":"32","author":[{"given":"Hideki","family":"Nagano","sequence":"first","affiliation":[{"name":"Department of Surgery, Marunouchi Hospital, Matsumoto 390-8601, Nagano, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigekazu","family":"Ohyama","sequence":"additional","affiliation":[{"name":"Department of Surgery, Marunouchi Hospital, Matsumoto 390-8601, Nagano, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Surgery, Marunouchi Hospital, Matsumoto 390-8601, Nagano, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Marunouchi Hospital, Matsumoto 390-8601, Nagano, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Surgery, Marunouchi Hospital, Matsumoto 390-8601, Nagano, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiko","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Marunouchi Hospital, Matsumoto 390-8601, Nagano, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/1097-0142(19900801)66:3<587::AID-CNCR2820660330>3.0.CO;2-J","article-title":"Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension","volume":"66","author":"Illes","year":"1990","journal-title":"Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045894019851000","article-title":"Pulmonary tumor thrombotic microangiography: A systemic review","volume":"9","author":"Godbole","year":"2019","journal-title":"Pulm. Circ."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2169\/internalmedicine.52.9472","article-title":"Pulmonary tumor thrombotic microangiopathy: A clinical analysis of 30 autopsy cases","volume":"52","author":"Uruga","year":"2013","journal-title":"Intern. Med."},{"key":"ref_4","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11523-022-00909-7","article-title":"Treatment patterns of real-world patients with TRK fusion cancer treated by US community oncologists","volume":"17","author":"Klink","year":"2022","journal-title":"Target. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/path.6341","article-title":"TRKing down drug resistance in NTRK fusion-positive cancers","volume":"264","author":"Parrish","year":"2024","journal-title":"J. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lange, A.M., and Lo, H.W. (2018). Inhibiting TRK proteins in clinical cancer therapy. Cancers, 10.","DOI":"10.3390\/cancers10040105"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/MCP.0000000000000297","article-title":"Pulmonary tumor thrombotic microangiopathy","volume":"22","author":"Price","year":"2016","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1159\/000508362","article-title":"A case of pulmonary tumor thrombotic microangiopathy suggested by the presence of tumor cells in peripheral blood","volume":"13","author":"Kawanaka","year":"2020","journal-title":"Case Rep. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Utsu, Y., Kawakami, M., Arai, H., Hisamatsu, H., Yano, Y., and Terada, J. (2023). Pulmonary tumor thrombotic microangiopathy during good response to immune-chemotherapy for advanced non-small cell lung cancer: A case report. BMC Pulm. Med., 23.","DOI":"10.1186\/s12890-023-02419-2"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"djx089","DOI":"10.1093\/jnci\/djx089","article-title":"ALK, ROS1, and NTRK rearrangements in metastatic colorectal cancer","volume":"109","author":"Pietrantonio","year":"2017","journal-title":"J. Nat. Cancer Inst."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/14728222.2021.1978070","article-title":"NTRK fusions in colorectal cancer: Clinical meaning and future perspective","volume":"25","author":"Ratt","year":"2021","journal-title":"Exp. Opin. Ther. Targets"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41698-021-00206-y","article-title":"Genomic context of NTRK1\/2\/3 fusion-positive tumors from a large real-world population","volume":"5","author":"Westphalen","year":"2021","journal-title":"NPJ Precis. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.20892\/j.issn.2095-3941.2024.0026","article-title":"Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants","volume":"21","author":"Chen","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e70665","DOI":"10.1002\/cam4.70665","article-title":"Tumor mutation burden survey of AACR GENIE database revealed NTRK (NTRK+) and RET (RET+) fusions positive colorectal carcinoma (CRC) as distinct subsets","volume":"14","author":"Arter","year":"2025","journal-title":"Cancer Med."},{"key":"ref_16","first-page":"e76842","article-title":"A rapid review of adenocarcinoma and pulmonary tumor thrombotic microangiopathy: A deadly duo","volume":"17","author":"Gayibov","year":"2025","journal-title":"Cureus"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/9\/506\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:44:09Z","timestamp":1760035449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/9\/506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":16,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["curroncol32090506"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32090506","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}